Loading stock…

Smith & Nephew plc (SNN) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

Smith & Nephew plc

SNNMarket cap $11BPrice $26.9

Country🇬🇧United Kingdom

SectorHealthcare

IndustryHealthcare Equipment

Makes artificial joints, wound care products, and surgical devices that help bodies heal and move again. One of the world's oldest medical device makers, it's been reconstructing knees and hips since before the NHS even existed.

In Bastion Portfolios?

52W Return-25%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+6%5

Revenue Forecast

Rev CAGR (1y)+5%4

Rev CAGR (3y)+5%4

Rev CAGR (5y)+5%5

Earnings Forecast

EPS Growth Y+1+54%9

EPS Growth Y+2+6%6

EPS Growth Y+3+14%7

Quality

Margins

EBIT Margin14%6

Net Income Margin10%6

Free Cash Flow Margin14%7

Debt

Net Debt/EBITDA2.14

Efficiency

ROE12%5

ROA6%7

Earnings Stability55

GEAR+AVERAGE60

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)118

P/E Ratio (Forward 3y)203

P/BV2.26

EV Multiples

EV/EBITDA Fwd87

EV/EBIT Fwd118

Yield

Free Cash Flow Yield7.5%8

Dividend Yield2.2%6

Momentum

Short term

1 month return-2%7

3 month return-9%4

YTD return-16%3

Mid term

Price vs 52wHigh74%4

1 year return-23%2

Long term

3 year return+22%4

5 year return-10%3

Risk Shield

Price Risk

Beta0.76

Volatility28%7

Free Cash Flow

Free Cash Flow Margin14%7

Free Cash Flow Yield7.5%8

Quality

ROCE10%6

Earnings Stability55

Net Debt/EBITDA2.14

02Growth

Is it actually growing, and how fast?

SNNSmith & Nephew

Revenue FY25$6.2B

GROWTH RATING↗

AVERAGE42 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+6%5

Revenue, next 1Y+5%4

Revenue, next 3Y, CAGR+5%4

Revenue, next 5Y, CAGR+5%5

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+54%9

EPS growth, FY27E+6%6

EPS growth, FY28E+14%7

GROWTH ASSESSMENT

STRENGTHS

Earnings are set to grow faster than sales (EPS about 14%/yr vs revenue 5%/yr), so margins should widen.

WATCH

A mid-pack grower, ahead of 42% of companies worldwide.

Revenue is set to grow 5%/yr over the next 3 years, a little behind the market.4/10

Revenue grew 6%/yr over the last 3 years and is set to keep growing around 5%/yr.

Over five years revenue is set to grow 5%/yr, about average versus companies worldwide.5/10

WEAKNESSES

None flagged.

BOTTOM LINE

Margin Expander

A middle-of-the-pack grower. The one thing to watch: forward revenue growth is only about average.

03Price Momentum

Is the market behind it right now?

SNNSmith & Nephew

Total return Current4.8%

Price return Current−10.6%

MOMENTUM RATING↗

WEAK24 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-2%7

3-month return-9%4

YTD return-16%3

MID & LONG-TERM▾SCORE

% of 52-week high74%4

1-year return-23%2

3-year return+22%4

5-year return-10%3

MOMENTUM ASSESSMENT

STRENGTHS

Strong recent results. The stock is outperforming over the past month (-2%).

WATCH

Returns sit at the market level over three months (-9%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (+22% over three years and -10% over five), behind 60% of the market.

It's down 23% over the past year, now 26% below its 52-week high. That is lagging the market.

The stock is underperforming so far this year (-16%).

BOTTOM LINE

Falling Knife

Returns rank poorly over both the short and long run, and the price is still falling. Momentum is firmly negative — catching this is a bet against the tape, not with it. Wait for a base to form. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Smith & Nephew. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

SNNSmith & Nephew

Revenue FY25$6.2B

GROWTH RATING↗

AVERAGE42 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+6%5

Revenue, next 1Y+5%4

Revenue, next 3Y, CAGR+5%4

Revenue, next 5Y, CAGR+5%5

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+54%9

EPS growth, FY27E+6%6

EPS growth, FY28E+14%7

GROWTH ASSESSMENT

STRENGTHS

Earnings are set to grow faster than sales (EPS about 14%/yr vs revenue 5%/yr), so margins should widen.

WATCH

A mid-pack grower, ahead of 42% of companies worldwide.

Revenue is set to grow 5%/yr over the next 3 years, a little behind the market.4/10

Revenue grew 6%/yr over the last 3 years and is set to keep growing around 5%/yr.

Over five years revenue is set to grow 5%/yr, about average versus companies worldwide.5/10

WEAKNESSES

None flagged.

BOTTOM LINE

Margin Expander

A middle-of-the-pack grower. The one thing to watch: forward revenue growth is only about average.

03Price Momentum

Is the market behind it right now?

SNNSmith & Nephew

Total return Current4.8%

Price return Current−10.6%

MOMENTUM RATING↗

WEAK24 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-2%7

3-month return-9%4

YTD return-16%3

MID & LONG-TERM▾SCORE

% of 52-week high74%4

1-year return-23%2

3-year return+22%4

5-year return-10%3

MOMENTUM ASSESSMENT

STRENGTHS

Strong recent results. The stock is outperforming over the past month (-2%).

WATCH

Returns sit at the market level over three months (-9%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (+22% over three years and -10% over five), behind 60% of the market.

It's down 23% over the past year, now 26% below its 52-week high. That is lagging the market.

The stock is underperforming so far this year (-16%).

BOTTOM LINE

Falling Knife

04Value

Are you paying a fair price for it?

Stop guessing on Smith & Nephew. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community